Abstract:Abstract Abstract 4377 Background: Myeloid Sarcoma (MS) is a rare neoplasm composed of immature myeloid cells occurring in any extramedullary organ most commonly in the skin, bone and lymph node. It may develop independently or concurrently with acute myeloid leukemia (AML), myeloproliferative disorder (MPD) or myelodysplastic syndrome (MDS). Some reports have described MS while most of them were one case report. In this study we retrospectively analyzed the clinical characteristics, treatment approaches and prognosis of 18 MS patients in our single center. Methods: between January 2003 and March 2010, eighteen MS patients were included in this study. The diagnosis depends on histological features and immunohistochemical results. All pathology specimens were routinely processed and examined by morphology. Immunohistochemical stains were performed on paraffin-embedded sections with monoclonal antibodies including MPO, CD3, CD20, CD79a, CD45, CD34, CD117, CD43. At the same time bone marrow aspiration were routinely examined. Disease morphology was determined according to the French-American – British(FAB) classification. After patients had comfirmed diagnosis with MS, they received cytarabine plus idarubicin or homoharringtonine for induction and consolidation chemotherapy. All the statistical analyses were performed using Kaplan-Meier. Results: among the 18 patients, the proportion of male and female was 1:1. Median age at diagnosis was 31.5 years (range 18–67). The usual involvement sites were skin (25%), lymph node (20%), breast (15%), uterus and cervix (15%). In total ten of the eighteen patients (55.6%) preceded AML without abnormality in peripheral blood and bone marrow while five patients concurrently developed AML-M2 and three (22.2%) were initially misdiagnosed as two were mistaken for Non-Hodgkin's lymphoma and the other for myeloma. In total 14 of 18 patients were examined by immunohistochemistry. The positive rate of MPO was 92.9% and other myeloid related markers were also strongly positive whereas lymphoid related markers were negative which were accord with biologic properties of myeloid cells. All the patients received chemotherapy. 10 patients without bone marrow involvement achieved complete disappearance of MS. Of these, 5 (50%) patients still kept complete remission after 1 year, 3 progressed to AML after six, eight and sixty-two months respectively; 2 died after two months after definite diagnoses of AML. As for the 6 patients with bone-marrow involvement undgone chemotherapy, 5 (83.3%) achieved complete bone-marrow remission but 3 of them relapsed at the points of seven,eleven and eighteen months, respectively. 4-year EFS and OS were longer in non-leukemic MS patients than in MS cases with bone-marrow involvement using Kaplan-Meier analyses. Conclusion: this study showed myeloid sarcoma could develop in various kinds of populations with easy misdiagnosis. Non-leukemic MS should be the beginning stage of AML. It is necessary to treat patients who have non-leukemic MS by classic chemical therapy for AML as early as possible. As such a study is limited by relatively small sample size, more clinical prospective trials in multiple centers should be carried out worldwide. Disclosures: No relevant conflicts of interest to declare.

An isolated sacral promyelocytic sarcoma in a child: A rare case report with emphasis on cytomorphology

Sarcomatoid Morphology in Pediatric Langerhans Cell Neoplasm Does Not Always Predict Aggressive Clinical Course

Unusual Presentation of Myeloid Sarcoma as Thigh Mass

Myeloid Sarcoma: a Clinical Report of 18 Cases

Spinal myeloid sarcoma presenting as initial symptom in acute promyelocytic leukemia with a rare cryptic PLZF::RARα fusion gene: a case report and literature review

Undifferentiated Sarcoma of the Soft Tissues with Cystic Degeneration: Case Report and Review of Literature

Isolated Duodenal Myeloid Sarcoma Associated with the CBFβ/MYH11 Fusion Gene Followed by Acute Myeloid Leukemia Progression: A Case Report and Literature Review.

An unusual case of mediastinal mass with pleural and pericardial effusion

CNS erythroblastic sarcoma: a potential emerging pediatric tumor type characterized by NFIA::RUNX1T1/3 fusions

A solitary scalp mass as the presenting feature of clear cell sarcoma of the kidney in a pediatric patient

Cytohistological findings and diagnostic challenges in rare pediatric pulmonary mesenchymal malignancies: A report of two cases

Pleomorphic Rhabdomyosarcoma: A Systematic Review with Outcome Analysis and Report of a Rare Abdominal Wall Lesion

Unveiling the Uncommon: A Unique Case of ALPS-Like Syndrome Complicated by Plasma Cell Disorder

Lumbar spine Ewing sarcoma: A report of a rare localization

Isolated recurrence of acute myeloid leukemia in the cerebellum: illustrative case

A Rare Case of Renal Sarcoma Mimicking Metastatic Osteosarcoma

Isolated myeloid sarcoma with pericardial and pleural effusions as first manifestation: A case report

A Case of Myxoid Pleomorphic Liposarcoma with Rhabdoid Cells: A Diagnostic Pitfall

A Pediatric Primary Cardiac Spindle Cell Neoplasm With a Rare PDGFRA::USP8 Gene Fusion: A Case Report

Pediatric presacral tumors with intraspinal extension: a rare entity with diagnostic challenges

Pediatric Undifferentiated Pleomorphic Sarcoma of the Cecum